CN107259003B - A kind of lycium ruthenicum Moringa ginseng health protection tea and its application - Google Patents
A kind of lycium ruthenicum Moringa ginseng health protection tea and its application Download PDFInfo
- Publication number
- CN107259003B CN107259003B CN201710334173.0A CN201710334173A CN107259003B CN 107259003 B CN107259003 B CN 107259003B CN 201710334173 A CN201710334173 A CN 201710334173A CN 107259003 B CN107259003 B CN 107259003B
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- moringa
- ginseng
- lycium ruthenicum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 39
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 39
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 39
- 235000011347 Moringa oleifera Nutrition 0.000 title claims abstract description 36
- 241000169546 Lycium ruthenicum Species 0.000 title claims abstract description 35
- 230000036541 health Effects 0.000 title claims abstract description 21
- 244000179886 Moringa oleifera Species 0.000 title claims abstract 6
- 244000269722 Thea sinensis Species 0.000 title claims abstract 5
- 244000131316 Panax pseudoginseng Species 0.000 title 1
- 241000208340 Araliaceae Species 0.000 claims abstract description 39
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 16
- 241000234435 Lilium Species 0.000 claims abstract description 15
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 15
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 15
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 230000007958 sleep Effects 0.000 claims abstract description 14
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 2
- 201000001421 hyperglycemia Diseases 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000036772 blood pressure Effects 0.000 abstract description 8
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000002265 prevention Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 210000000056 organ Anatomy 0.000 abstract description 2
- 150000003254 radicals Chemical class 0.000 abstract description 2
- 241000220215 Moringa Species 0.000 description 31
- 241001122767 Theaceae Species 0.000 description 24
- 230000000694 effects Effects 0.000 description 17
- 238000011282 treatment Methods 0.000 description 16
- 210000004556 brain Anatomy 0.000 description 11
- 238000011443 conventional therapy Methods 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 4
- -1 blood pressure Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000002710 Ilex cornuta Nutrition 0.000 description 2
- 241001310146 Ilex cornuta Species 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241001247821 Ziziphus Species 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000036995 brain health Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000003181 encephalopathic effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of lycium ruthenicum Moringa ginseng health protection tea and its application, in mass ratio, including 25 35 parts of lycium ruthenicum, 15 25 parts of leaf of Moringa, 15 25 parts of ginseng, 5 15 parts of gingko, 5 15 parts of lily, 5 15 parts of lotus seeds.The present composition can be with（1）Improve the immunity of the human body, blood pressure lowering, hypoglycemic, reducing blood lipid.（2）Fatigue-relieving, promote sleep.（3）Remove free radical, anti-aging.By the complex function of the raw materials such as lycium ruthenicum, leaf of Moringa, ginseng, gingko, lily, lotus seeds, drunk with tea generation, nurse one's health the function of each organ of human body, achieve the purpose that " putting prevention first and combining prevention with control ".
Description
Technical field
The present invention relates to a kind of field of health-care tea, available for blood glucose, blood pressure, blood fat and the sleep for preparing three high crowds for the treatment of
The product of obstacle.
Background technology
China is drinks tea big country, and tea culture is of long standing and well established, and the health beverages species of in the market is various, effect be also the good and the bad not
Together.With China's expanding economy, country the rich and powerful and improvement of people's living standards, dietary structure occur great change, " three
Height " crowd is in the situation risen year by year, and body and mind inferior health causes a significant threat quality of life, is caused national and society wide
General concern, the survey showed that by one of WHO announcements, and the population of whole world true health only accounts for 5%, and inferior health population accounts for
75%, remaining is morbid state.
Wild lycium ruthenicum is one kind that category is Solanaceae Lycium, sweet in flavor, mild-natured；Berry is spherical, thin skin, is purple black after ripe
Color.It is relatively abundant that K, Na, Fe, Ca, Mg are included in black fruit fructus lycii, especially the content of K will be significantly larger than the content of sodium, be a kind of allusion quotation
The fruit of the hyperkalemia hyponatremia of type, and Fe, Se, Zn content are similar to pork liver, higher than all fruit and vegetable juices, its medicinal health value is much
Higher than red matrimony vine, it is known as " soft gold ".It, which includes abundant anthocyanin element and procyanidine, has preventing hypertension, the protection heart
Blood vessel, antitumor, protection eyesight and the effect such as promote longevity；The flavone compound such as the rutin included and Quercetin has anti-ageing
The effect of old and reducing blood lipid, the prevention available for atherosclerosis.
Moringa Moringaceae, Moringa, are a kind of perennial tropical plants with unique economic value, are distributed mainly on
More than 30 tropical, semi-tropical countries and regions such as India, China, Japan, Egypt, U.S..Rich in VA、VB、VC、VEAnd Ca, K,
The mineral nutrient elements such as Fe, wherein Ca and protein content are respectively 4 times and 2 times of milk, and K is 3 times of banana, and Fe is spinach
3 times, VCIt is 7 times of citrus, VAIt is 4 times of carrot, is known as " tree of miracle ", complete stool is all available, nutriment species
It is more.Leaf juice has effects that stabilizing blood pressure and treatment are melancholy；The glucose level of controllable diabetes patient；Rubbed with leaf and tender shoots
Temple treatment headache；Mud application can treat the diseases such as glandular hyperplasia, ulcer and skin infection made of fresh leaf；Edible blade
Milk volume can be increased, and have the effect for the treatment of anemia.
Ginseng is dry for the dry root of Araliaceae thing ginseng, is Relict Plant, and precious Chinese medicine, in China's medicinal history
It is long.Ginseng can adjust central nervous system, promote utilization of the brain to energy matter, and ginseng can increase myocardial contractive power, subtract
Slow heart rate, increases cardiac output and coronary blood flow, can resist myocardial ischemia and arrhythmia cordis, contains ginsenoside and people in ginseng
Gracilis polysaccharide, especially ginsenoside Rb2 have obvious hypoglycemic effect, strengthen the immune function of body, improve to destructive stimulus
Resilience, the stress ability and adaptability of body, antitumor action, antioxidation can be strengthened.
CN105494795A makes the raw materials such as dry lycium ruthenicum fruit, dried hawthorn, jujube nucleus, rock sugar, persimmon leaves, chrysanthemum a kind of
Lycium ruthenicum health protection tea, only has the function that to promote sleep；CN 104757216A ginseng fibrous roots concentrate, jujube concentrate, Angelica sinensis are dense
The raw materials such as contracting liquid, oriental wormwood concentrate make ginseng tea, the only effect with fatigue-relieving, both are adjusted without components such as leaf of Moringa
The effect of body immunity is weaker；
Patent CN 105558178A, CN 102524470A describe a kind of Moringa leaf tea and the processing method of gingko, but
Component is single, does not possess the effect of compound adjusting body immunity；
In conclusion in prior art, the single health beverages of component, the effect without combined cooker body immunity
Fruit.The component such as composite health care drink, no leaf of Moringa, the effect for nursing one's health body immunity are weaker.
The content of the invention
The technical problem of solution：The present invention provides a kind of health protection tea, by drinking the health protection tea, improves the immunity of the human body,
Reduce by three excessive risks；" three high " crowd drinks health protection tea, coordinates drug therapy, optimizes body indices, improves the quality of living.
Technical solution：A kind of health protection tea composition, it is characterised in that in mass ratio, including 25-35 parts of lycium ruthenicum, leaf of Moringa
15-25 parts, 15-25 parts of ginseng, 5-15 parts of gingko, 5-15 parts of lily, 5-15 parts of lotus seeds.
Preferably, the component of above-mentioned health protection tea in mass ratio is：30 parts of lycium ruthenicum, 20 parts of leaf of Moringa, 20 parts of ginseng, gingko
10 parts, 10 parts of lily, 10 parts of lotus seeds.
Above-mentioned composition is preparing the application in treating hypertension product.
Above-mentioned composition is preparing the application in treating hyperglycaemia product.
Above-mentioned composition is preparing the application in treating hyperlipidemia product.
Above-mentioned composition is preparing the application in improving sleep product.
Beneficial effect：The present composition can (1) improve the immunity of the human body, blood pressure lowering, hypoglycemic, reducing blood lipid.(2) delay
Solution fatigue, promote sleep.(3) free radical, anti-aging are removed.Pass through lycium ruthenicum, leaf of Moringa, ginseng, gingko, lily, lotus seeds etc.
The complex function of raw material, is drunk with tea generation, nurses one's health the function of each organ of human body, achieve the purpose that " putting prevention first and combining prevention with control ".
Embodiment
Embodiment 1
Lycium ruthenicum tea-drinking, Moringa ginseng mixing tea-drinking and lycium ruthenicum Moringa ginseng tea are drunk case history in three high crowd's clinics and are seen
Examine：
By mass parts
A is formulated：70 parts of lycium ruthenicum, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds；
B is formulated：35 parts of leaf of Moringa, 35 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds；
C is formulated：30 parts of lycium ruthenicum, 20 parts of leaf of Moringa, 20 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds.
Preparation method
After each component in formula is crushed, dispensing in proportion, dried 20~30 mesh sieves and obtains product after mixing, during use
Brewed with boiling water up to tea-drinking.
1st, three high crowd's conventional therapies are observed and A formulas tea-drinking is drunk in packet, B is formulated tea-drinking and C matches somebody with somebody in conventional therapy
The clinical application effect contrast of square tea-drinking.
Applicant is formulated tea-drinking from March, 2013 to part of in September, 2016 to drinking A formulas tea-drinking, B formula tea-drinkings and C
The influence for reducing diabetes B blood glucose, blood pressure, blood lipid metabolism and Advanced glycation endproducts (AGEs) carries out observational study.
2nd, selection is in hospital and random be grouped into of the diabetes B patient 90 by WHO standard of outpatient service drinks A formula tea
Drink, B formula tea-drinkings and C formula tea-drinkings are each 30 and does not take tea conventional therapy 30, alternative condition such as following table：
1 diabetic's clinical case overview of table
Observation index：Empty stomach 0h and 100g steamed bun 2h-plasma glucose and blood fat, and same sphygmomanometer is utilized, when same
Between, same person measurement blood pressure.
2 conventional therapy of table observes contrast record sheet with conventional therapy+A three high crowds of formula tea-drinking
3 conventional therapy+B of table is formulated tea-drinking and observes contrast record sheet to three high crowds with conventional therapy+C formula tea-drinkings
4th, experimental result
4.1 effect：Conventional therapy coordinates again drinks A formulas tea-drinking, B formulas tea-drinking, C formula tea-drinkings and conventional therapy phase
Than the blood glucose of, 3 observation groups, blood pressure, blood fat, AGEs compared with control group, there is improvement, specifically refer to table 4
4.2 adverse reaction：Experimental group A formula tea-drinking occur 3 slight abdominal distension adverse reaction, 2 it is small when after be relieved,
Other reasons are excluded to cause；5 0h-PG and 2h-PG is raised, and analysis reason is that sugar is higher in lycium ruthenicum and individual physique draws
, using C formula tea-drinkings instead, normally, other experimental groups and control group are normal for 5 blood glucose rise steering reduction recoveries after three months
Carry out.
4 experimental group of table and control group statistical result
5th, conclusion：
Lycium ruthenicum Moringa ginseng tea main component is lycium ruthenicum, leaf of Moringa, ginseng, gingko, lily and lotus seeds etc., wherein black Chinese holly
Qi, leaf of Moringa and ginseng are key component, remaining is helper component.
Matched somebody with somebody by being grouped in March, 2013 in September, 2016 to drink A and be formulated tea-drinking, B on the basis of conventional therapy diabetes
In the contrast experiment of square tea-drinking and C formula tea-drinking, it is found that A formula tea-drinking groups hypoglycemic, decompression, lipid-lowering effect are better than control group, it is low
In other observation groups, there are 5 blood glucose to raise, be because of lycium ruthenicum sugar and individual physique reason, use instead and drink C formulas, it is extensive
It is multiple normal；B formula tea-drinking groups hypoglycemic, decompression, lipid-loweringing and reduction AGEs positive effects are better than control group；C formula tea-drinking groups hypoglycemic,
Decompression, lipid-loweringing and reduction AGEs positive effects are better than other test groups, illustrate that C formula tea-drinkings have compound action, in hypoglycemic, drop
Pressure, the effect of lipid-loweringing are substantially better than A formula tea-drinkings group, the tea-drinking and control group of B formula tea-drinking groups.
In conclusion the various ingredients of lycium ruthenicum Moringa ginseng tea mutually cooperate with, in three high crowd of clinical treatment, to control
With stabilizing blood sugar, blood pressure, blood fat, reducing AGEs etc. has good auxiliary therapeutic action, hence it is evident that lifting minimal invasive treatment's matter
Amount.
Embodiment 2
Lycium ruthenicum tea-drinking, Moringa ginseng mixing tea-drinking and lycium ruthenicum Moringa ginseng tea improve the observation of sleep quality clinical case history：
By mass parts
A is formulated：30 parts of lycium ruthenicum, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds；
B is formulated：20 parts of leaf of Moringa, 20 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds；
C is formulated：30 parts of lycium ruthenicum, 20 parts of leaf of Moringa, 20 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds.
Preparation method
After each component in formula is crushed, dispensing in proportion, dried 20~30 mesh sieves and obtains product after mixing, during use
Brewed with boiling water up to tea-drinking.
1st, purpose is observed：Observe brain electric therapeutic instrument for rehabilitation and brain electric therapeutic instrument for rehabilitation+lycium ruthenicum tea-drinking, brain electricity rehabilitation
Instrument+Moringa ginseng mixing tea-drinking and brain electric therapeutic instrument for rehabilitation+lycium ruthenicum Moringa ginseng tea improve the clinical effectiveness of sleep quality.
2nd, method：In Fuyang, diabetes Hospital choice is in hospital insomniac 100, is randomly divided into 3 observation combinations each 25
Example and control group 25, control group are treated using encephalopathic therapeutic instrument for rehabilitation, and 3 groups of observation groups add with black Chinese holly on the basis of control group
Qi, Moringa ginseng mixing tea-drinking and lycium ruthenicum Moringa ginseng tea, the 2 Monday courses for the treatment of, observe four course for the treatment of result observation treatments respectively
The efficient statistical analysis of group.
2.1 control group：Brain electric therapeutic instrument for rehabilitation, once a day, the 2 Monday courses for the treatment of, treat 4 courses for the treatment of, middle uninterrupted.
2.2 observation group：On the basis of control group, adhere to drinking A formulas tea-drinking, B formulas tea-drinking, C formula tea-drinkings daily, 2
The Monday course for the treatment of, treats four courses for the treatment of, middle uninterrupted.
3rd, conclusion is judged
3.1 curative effect determinate standard：
Cure：Can continuously sleep 6 it is small when more than and the middle person that do not wake up.
Significantly：The middle person that wakes up more than when energy prolonged sleep 6 is small.
Effectively：The length of one's sleep when 4~6 is small among not wake up person.
4th, experimental record：
Progress clinical test on March 15th, 2013 was grouped and is tested in batches on the 25th to September in 2016, and gathered data is as follows
Table
Table 5, experimental group and control group statistical result
Take A formulas tea-drinking, B formula tea-drinkings and C and be formulated tea-drinking to sleep improvement conclusive table
Brain health instrument：Hundred strange Brain health instruments difficult to understand, YY-I types
5th, conclusion
Lycium ruthenicum Moringa ginseng tea main component is lycium ruthenicum, leaf of Moringa, ginseng, gingko, lily and lotus seeds etc., wherein black
Matrimony vine, leaf of Moringa and ginseng are key component, remaining is helper component.
Observation herein takes lycium ruthenicum tea-drinking, Moringa ginseng mixing tea-drinking and lycium ruthenicum Moringa ginseng tea and has a sleepless night in clinical treatment
Contrast experiment.
By March in 2013, the statistical result of 15 days to 2016 on Septembers, 25, clinical treatments showed, used brain Kang Yi merely
The person that do not wake up among more than when therapeutic equipment group 6 is small accounts for 52%；6 it is small when more than among wake up a person account for 24%；4~6 it is small when among not
Awake person accounts for 24%；It is obviously improved patient sleeps' mass.
The person that do not wake up among more than when brain Kang Yi+A formula tea-drinkings group 6 is small accounts for 60%；6 it is small when more than among wake up a person account for
24%；4~6 it is small when among wake up person account for 16%；Compared with control group, there is the effect for being obviously improved sleep quality.
The person that do not wake up among more than when brain Kang Yi+B formula tea-drinkings group 6 is small accounts for 56%；6 it is small when more than among wake up a short time
Sleep person accounts for 24%；4~6 it is small when among wake up person account for 20%；Effect is better than control group, not as good as brain Kang Yi+lycium ruthenicum tea-drinking group.
The person that do not wake up among more than when brain Kang Yi+C formula tea-drinkings group 6 is small accounts for 72%；6 it is small when more than among wake up a short time
Sleep person accounts for 20%；4~6 it is small when among wake up person account for 8%, the best results in all experimental groups.
In conclusion the various ingredients of lycium ruthenicum Moringa ginseng tea mutually cooperate with, it is right during clinical treatment insomnia crowd
Promote sleep etc. that there is good auxiliary therapeutic action.
Claims (6)
1. a kind of health protection tea composition, it is characterised in that in mass ratio by 25-35 parts of lycium ruthenicum, 15-25 parts of leaf of Moringa, ginseng
15-25 parts, 5-15 parts of gingko, 5-15 parts of lily, 5-15 parts of lotus seeds composition.
2. health protection tea composition according to claim 1, it is characterised in that 30 parts of the lycium ruthenicum, 20 parts of leaf of Moringa, people
20 parts of ginseng, 10 parts of gingko, 10 parts of lily, 10 parts of lotus seeds.
3. the composition of claim 1 or 2 is preparing the application in treating hypertension product.
4. the composition of claim 1 or 2 is preparing the application in treating hyperglycaemia product.
5. the composition of claim 1 or 2 is preparing the application in treating hyperlipidemia product.
6. the composition of claim 1 or 2 is preparing the application in improving sleep product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710334173.0A CN107259003B (en) | 2017-05-12 | 2017-05-12 | A kind of lycium ruthenicum Moringa ginseng health protection tea and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710334173.0A CN107259003B (en) | 2017-05-12 | 2017-05-12 | A kind of lycium ruthenicum Moringa ginseng health protection tea and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107259003A CN107259003A (en) | 2017-10-20 |
| CN107259003B true CN107259003B (en) | 2018-04-20 |
Family
ID=60073923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710334173.0A Expired - Fee Related CN107259003B (en) | 2017-05-12 | 2017-05-12 | A kind of lycium ruthenicum Moringa ginseng health protection tea and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107259003B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107691720A (en) * | 2017-11-08 | 2018-02-16 | 王中菊 | A kind of Moringa nurses one's health health protection tea |
| CN109527319A (en) * | 2018-12-19 | 2019-03-29 | 九道通(北京)企业管理有限公司 | Lycium ruthenicum Instant Drinks solid beverage with oxidation and removing free radicals |
| CN115634258B (en) * | 2022-09-08 | 2023-09-19 | 长春中医药大学 | Chinese herbal compound preparation capable of reducing blood pressure and preparation method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200607518A (en) * | 2004-08-18 | 2006-03-01 | Yuan-Hung Jang | Swirled iron-core generator hub |
| CN102423407B (en) * | 2011-12-09 | 2013-06-12 | 兰州古驰生物科技有限公司 | Chinese medicinal composition for conditioning subhealth state |
| CN105230860A (en) * | 2015-06-19 | 2016-01-13 | 杨初 | Blending and making method of horseradish tree formula bag-brewing type medicinal tea |
| CN105124347A (en) * | 2015-07-24 | 2015-12-09 | 海南木辣达生物科技有限公司 | Moringa oleifera blood-glucose-reducing composition and preparation method thereof |
| CN106106925A (en) * | 2016-06-28 | 2016-11-16 | 禹州市鼎信中药科技有限公司 | A kind of Radix Ginseng agate click alternative tea formula and production technology thereof |
| CN106234712A (en) * | 2016-09-05 | 2016-12-21 | 广东分子态生物股份有限公司 | A kind of freely assorted instant alternative tea and preparation method thereof |
-
2017
- 2017-05-12 CN CN201710334173.0A patent/CN107259003B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN107259003A (en) | 2017-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107259571A (en) | One kind is for canteen thing and preparation method thereof | |
| CN103054113B (en) | Composite fruit-vegetable juice beverage with blood sugar decreasing effect | |
| CN101664175A (en) | Natural five-color coarse cereal-melon-vegetable tea porridge and method for making same | |
| CN107279981A (en) | Composite plant zymotic fluid and its zymotechnique and application | |
| CN103653144B (en) | Healthcare drink capable of improving immunity and preparation method thereof | |
| CN102987477B (en) | Health drink | |
| CN107259003B (en) | A kind of lycium ruthenicum Moringa ginseng health protection tea and its application | |
| CN106072527A (en) | A kind of natto prescription of eliminating toxin and beautifying the skin and preparation method thereof | |
| KR20150040392A (en) | undiluted stevia liquid and the berages, and its manufacturing method | |
| CN105249065B (en) | A kind of grape apple composite beverage for improving immunity | |
| CN104397792A (en) | Making method for Pleurotus eryngii ginger juice beverage | |
| CN109937795B (en) | Method for cultivating cordyceps sinensis mycelia by taking jasmine as matrix | |
| CN107019208A (en) | A kind of Chinese medicine ferment and preparation method thereof | |
| CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
| CN104886696A (en) | Ganoderma lucidum fetus protecting fruit vinegar drink | |
| CN104450470A (en) | Cudrania tricuspidata fruit health care wine and preparation method thereof | |
| CN108077485A (en) | A kind of blue or green money willow herbal tea and preparation method thereof | |
| CN107125521A (en) | A kind of fermenting plant beverage for improving sleep and preparation method thereof | |
| KR101058422B1 (en) | Herbal dietary supplement and its manufacturing method | |
| CN108159191B (en) | Composition for tonifying yang and invigorating kidney, application and oral liquid and preparation method thereof | |
| CN103436416B (en) | Anti-hypertension healthcare wine and production method thereof | |
| CN105747063A (en) | Muskmelon fermented carbonated beverage | |
| CN105087285A (en) | Compound mulberry health wine and preparation method thereof | |
| KR102621081B1 (en) | Method for manufacturing seasoning sauce for shellfish and seafood | |
| CN108967774A (en) | A kind of nectar and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: 236000 Fuyang Economic Development Zone in Anhui Province, south of eight road, Guozhen power plant on the west side of four road. Patentee after: ANHUI AIHUATE BIOTECHNOLOGY CO.,LTD. Address before: 236113 Yingzhou District, Fuyang, Anhui, Fuyang Hefei modern industrial park, Hefei Avenue, No. 16, B-7 Patentee before: ANHUI AIHUATE BIOTECHNOLOGY CO.,LTD. |
|
| CP02 | Change in the address of a patent holder | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180420 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |